Patient Satisfaction With Public Pharmacy Services: Structural and Policy Implications From Greece

被引:0
作者
Karakolias, Stefanos [1 ]
Georgi, Christina [2 ]
Georgis, Vasileios [1 ]
机构
[1] Hellen Open Univ, Post Grad Programme Hlth Care Management, Patras, Greece
[2] Univ Patras, Business Adm Dept, Patras, Greece
关键词
greece; medicinal advise; high-cost drugs; eopyy pharmacies; public pharmacies; patient satisfaction; IMPACT; VALIDATION; MEDICINES; CULTURE; CRISIS; VIEWS; CARE;
D O I
10.7759/cureus.58654
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study aimed at investigating patient satisfaction with services offered by a certain type of public pharmacies in Greece (National Organisation for Healthcare Provision (EOPYY) pharmacies), tasked with dispensing mostly high -cost drugs, in an effort to highlight the aspects to be optimized. Methods The Patient Satisfaction with Pharmacist Services Questionnaire 2.0 (PSPSQ 2.0) questionnaire was the main instrument of our research. We received 201 full responses from patients themselves and patients' companions who had visited EOPYY pharmacies in Athens, the capital city of Greece, from October 2022 to January 2023. Results Patients seem satisfied with public pharmacies in general. In fact, the professionalism of the pharmacists, the respect that patients have received from them, and the information and explanations that were given by pharmacists, received a very high score. On the other hand, the parameters referred to the information that patients received from pharmacists for the overall improvement of their health had the lowest score, revealing an apparent lag in the field of medicinal advice. Conclusion Without any doubt, patients expect their pharmacists to be more guiding and to better communicate this role. This requires more time to be spent with patients, focused training, teamwork, layout, and other organizational interventions.
引用
收藏
页数:9
相关论文
共 30 条
[21]   Development and validation of PSPSQ 2.0 measuring patient satisfaction with pharmacist services [J].
Sakharkar, Prashant ;
Bounthavong, Mark ;
Hirsch, Jan D. ;
Morello, Candis M. ;
Chen, Timothy C. ;
Law, Anandi V. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2015, 11 (04) :487-498
[22]   A segmentation analysis for pharmacists' and patients' views of pharmacists' roles [J].
Schommer, Jon C. ;
Gaither, Caroline A. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2014, 10 (03) :508-528
[23]   Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece - the HOPE II Study [J].
Souliotis, Kyriakos ;
Alexopoulou, Elena ;
Papageorgiou, Manto ;
Politi, Anastasia ;
Litsa, Panagiota ;
Contiades, Xenophon .
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2016, 5 (02) :83-89
[24]   Barriers to accessing biologic treatment for rheumatoid arthritis in Greece: the unseen impact of the fiscal crisis-the Health Outcomes Patient Environment (HOPE) study [J].
Souliotis, Kyriakos ;
Papageorgiou, Manto ;
Politi, Anastasia ;
Ioakeimidis, Dimitrios ;
Sidiropoulos, Prodromos .
RHEUMATOLOGY INTERNATIONAL, 2014, 34 (01) :25-33
[25]   ON THE EFFICIENCY OF USING THE SAMPLE KURTOSIS IN SELECTING OPTIMAL LP ESTIMATORS [J].
SPOSITO, VA ;
HAND, ML ;
SKARPNESS, B .
COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION, 1983, 12 (03) :265-272
[26]   Exploratory factor analysis revisited: How robust methods support the detection of hidden multivariate data structures in IS research [J].
Treiblmaier, Horst ;
Filzmoser, Peter .
INFORMATION & MANAGEMENT, 2010, 47 (04) :197-207
[27]  
Wilson DavidT., 1995, J ACAD MARKET SCI, V23, P335, DOI [10.1177/009207039502300410, DOI 10.1177/009207039502300414]
[28]   Creating a "just culture": More work to be done [J].
Wu, Albert W. ;
Kachalia, Allen B. .
JOURNAL OF PATIENT SAFETY AND RISK MANAGEMENT, 2023, 28 (02) :56-58
[29]   Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Patient-reported outcome measures [J].
Wuyts, Joke ;
Maesschalck, Joris ;
De Wulf, Isabelle ;
De Lepeleire, Jan ;
Foulon, Veerle .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (12) :1760-1767
[30]  
Yfantopoulos John N, 2018, Value Health Reg Issues, V16, P66, DOI [10.1016/j.vhri.2018.06.006, 10.1016/j.vhri.2018.06.006]